226 related articles for article (PubMed ID: 26066796)
1. Galectin-1, -3 and -9 Expression and Clinical Significance in Squamous Cervical Cancer.
Punt S; Thijssen VL; Vrolijk J; de Kroon CD; Gorter A; Jordanova ES
PLoS One; 2015; 10(6):e0129119. PubMed ID: 26066796
[TBL] [Abstract][Full Text] [Related]
2. Roles of galectin-7 and S100A9 in cervical squamous carcinoma: Clinicopathological and in vitro evidence.
Zhu H; Wu TC; Chen WQ; Zhou LJ; Wu Y; Zeng L; Pei HP
Int J Cancer; 2013 Mar; 132(5):1051-9. PubMed ID: 22864818
[TBL] [Abstract][Full Text] [Related]
3. Systems-level effects of ectopic galectin-7 reconstitution in cervical cancer and its microenvironment.
Higareda-Almaraz JC; Ruiz-Moreno JS; Klimentova J; Barbieri D; Salvador-Gallego R; Ly R; Valtierra-Gutierrez IA; Dinsart C; Rabinovich GA; Stulik J; Rösl F; Rincon-Orozco B
BMC Cancer; 2016 Aug; 16(1):680. PubMed ID: 27558259
[TBL] [Abstract][Full Text] [Related]
4. Galectin 1 expression is associated with tumor invasion and metastasis in stage IB to IIA cervical cancer.
Kim HJ; Do IG; Jeon HK; Cho YJ; Park YA; Choi JJ; Sung CO; Lee YY; Choi CH; Kim TJ; Kim BG; Lee JW; Bae DS
Hum Pathol; 2013 Jan; 44(1):62-8. PubMed ID: 22939954
[TBL] [Abstract][Full Text] [Related]
5. Psoriasis in humans is associated with down-regulation of galectins in dendritic cells.
de la Fuente H; Perez-Gala S; Bonay P; Cruz-Adalia A; Cibrian D; Sanchez-Cuellar S; Dauden E; Fresno M; García-Diez A; Sanchez-Madrid F
J Pathol; 2012 Oct; 228(2):193-203. PubMed ID: 22271227
[TBL] [Abstract][Full Text] [Related]
6. Tumor galectinology: insights into the complex network of a family of endogenous lectins.
Lahm H; André S; Hoeflich A; Kaltner H; Siebert HC; Sordat B; von der Lieth CW; Wolf E; Gabius HJ
Glycoconj J; 2004; 20(4):227-38. PubMed ID: 15115907
[TBL] [Abstract][Full Text] [Related]
7. The prostaglandin receptor EP2 determines prognosis in EP3-negative and galectin-3-high cervical cancer cases.
Dietlmeier S; Ye Y; Kuhn C; Vattai A; Vilsmaier T; Schröder L; Kost BP; Gallwas J; Jeschke U; Mahner S; Heidegger HH
Sci Rep; 2020 Jan; 10(1):1154. PubMed ID: 31980713
[TBL] [Abstract][Full Text] [Related]
8. The Role of Galectins in Cervical Cancer Biology and Progression.
Wang L; Zhao Y; Wang Y; Wu X
Biomed Res Int; 2018; 2018():2175927. PubMed ID: 29854732
[TBL] [Abstract][Full Text] [Related]
9. Galectins as markers of aggressiveness of mouse mammary carcinoma: towards a lectin target therapy of human breast cancer.
Moiseeva EV; Rapoport EM; Bovin NV; Miroshnikov AI; Chaadaeva AV; Krasilshschikova MS; Bojenko VK; Bijleveld C; van Dijk JE; Den Otter W
Breast Cancer Res Treat; 2005 Jun; 91(3):227-41. PubMed ID: 15952056
[TBL] [Abstract][Full Text] [Related]
10. Increased expression of galectin-1 during the progression of cervical neoplasia.
Kohrenhagen N; Volker HU; Kapp M; Dietl J; Kammerer U
Int J Gynecol Cancer; 2006; 16(6):2018-22. PubMed ID: 17177840
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of the alpha v beta 6 integrin in cervical squamous cell carcinoma is a prognostic factor for decreased survival.
Hazelbag S; Kenter GG; Gorter A; Dreef EJ; Koopman LA; Violette SM; Weinreb PH; Fleuren GJ
J Pathol; 2007 Jul; 212(3):316-24. PubMed ID: 17503414
[TBL] [Abstract][Full Text] [Related]
12. Tissue- and cell-specific localization of galectins, β-galactose-binding animal lectins, and their potential functions in health and disease.
Nio-Kobayashi J
Anat Sci Int; 2017 Jan; 92(1):25-36. PubMed ID: 27590897
[TBL] [Abstract][Full Text] [Related]
13. Galectin signatures contribute to the heterogeneity of breast cancer and provide new prognostic information and therapeutic targets.
Grosset AA; Labrie M; Vladoiu MC; Yousef EM; Gaboury L; St-Pierre Y
Oncotarget; 2016 Apr; 7(14):18183-203. PubMed ID: 26933916
[TBL] [Abstract][Full Text] [Related]
14. Clinical characteristics and prognostic significance of galectins for patients with gastric cancer: A meta-analysis.
Long B; Yu Z; Zhou H; Ma Z; Ren Y; Zhan H; Li L; Cao H; Jiao Z
Int J Surg; 2018 Aug; 56():242-249. PubMed ID: 29940258
[TBL] [Abstract][Full Text] [Related]
15. Peroxisome proliferator-activated receptor γ upregulates galectin-9 and predicts prognosis in intestinal-type gastric cancer.
Cho SJ; Kook MC; Lee JH; Shin JY; Park J; Bae YK; Choi IJ; Ryu KW; Kim YW
Int J Cancer; 2015 Feb; 136(4):810-20. PubMed ID: 24976296
[TBL] [Abstract][Full Text] [Related]
16. The analysis of metallothionein immunoreactivity in stromal fibroblasts and macrophages in cases of uterine cervical carcinoma with respect to both the local and distant spread of the disease.
Walentowicz-Sadlecka M; Koper A; Krystyna G; Koper K; Basta P; Mach P; Skret-Magierlo J; Dutsch-Wicherek M; Sikora J; Grabiec M; Kazmierczak W; Wicherek L
Am J Reprod Immunol; 2013 Sep; 70(3):253-61. PubMed ID: 23590599
[TBL] [Abstract][Full Text] [Related]
17. Tim-3/galectin-9 signaling pathway mediates T-cell dysfunction and predicts poor prognosis in patients with hepatitis B virus-associated hepatocellular carcinoma.
Li H; Wu K; Tao K; Chen L; Zheng Q; Lu X; Liu J; Shi L; Liu C; Wang G; Zou W
Hepatology; 2012 Oct; 56(4):1342-51. PubMed ID: 22505239
[TBL] [Abstract][Full Text] [Related]
18. Human galectin-8 isoforms and cancer.
Bidon-Wagner N; Le Pennec JP
Glycoconj J; 2002; 19(7-9):557-63. PubMed ID: 14758080
[TBL] [Abstract][Full Text] [Related]
19. FoxP3(+) and IL-17(+) cells are correlated with improved prognosis in cervical adenocarcinoma.
Punt S; van Vliet ME; Spaans VM; de Kroon CD; Fleuren GJ; Gorter A; Jordanova ES
Cancer Immunol Immunother; 2015 Jun; 64(6):745-53. PubMed ID: 25795131
[TBL] [Abstract][Full Text] [Related]
20. Expression of immune checkpoint molecules of T cell immunoglobulin and mucin protein 3/galectin-9 for NK cell suppression in human gastrointestinal stromal tumors.
Komita H; Koido S; Hayashi K; Kan S; Ito M; Kamata Y; Suzuki M; Homma S
Oncol Rep; 2015 Oct; 34(4):2099-105. PubMed ID: 26239720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
